(1 - 8 von 14
)
New partnership to accelerate development of | EurekAlert!www.eurekalert.org › news-releases
www.eurekalert.org
· ... development of new treatments for neurological diseases," said Chirfi Guindo, President and Managing Director, Merck Canada Inc.
Keytruda Approved as First-Line Lung Cancer Treatment in Canada –...
immuno-oncologynews.com
We look forward to working with provinces and other jurisdictions to ensure that Canadians who need immunotherapy for first-line treatment of metastatic NSLC have rapid access to Keytruda,” Chirfi Guindo, president and managing director of Merck Canada (known as MSD outside the U.S. and Canada), ...
How collaborative innovation is speeding up cancer research in Canada...
www.marsdd.com
“This announcement is a reaffirmation of Merck's commitment to the Canadian life science research innovation sector, which is particularly vibrant in this location at the centre of one of the world's largest urban innovation hubs,” said Chirfi Guindo, President and Managing Director of Merck Canada Inc. “We ...
sortiert nach Relevanz / Datum